Form 8-K - Current report:
SEC Accession No. 0001477932-24-005817
Filing Date
2024-09-18
Accepted
2024-09-18 14:13:25
Documents
16
Period of Report
2024-09-14
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bglc_8k.htm   iXBRL 8-K 26269
2 PRESS RELEASE bglc_ex991.htm EX-99.1 13473
  Complete submission text file 0001477932-24-005817.txt   171504

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bglc-20240914.xsd EX-101.SCH 5720
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bglc-20240914_lab.xml EX-101.LAB 15195
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bglc-20240914_cal.xml EX-101.CAL 898
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bglc-20240914_pre.xml EX-101.PRE 9631
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bglc-20240914_def.xml EX-101.DEF 2099
19 EXTRACTED XBRL INSTANCE DOCUMENT bglc_8k_htm.xml XML 4042
Mailing Address 10-2 TOWER B, VERTICAL BUSINESS SUITE, 8 JALAN KERINCHI, KUALA LUMPUR N8 59200
Business Address 10-2 TOWER B, VERTICAL BUSINESS SUITE, 8 JALAN KERINCHI, KUALA LUMPUR N8 59200 1-307-241-6898
BioNexus Gene Lab Corp (Filer) CIK: 0001737523 (see all company filings)

EIN.: 262124961 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41750 | Film No.: 241306943
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)